An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01838668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis

Interventions

DRUG: Placebo
DRUG: dimethyl fumarate

Sponsor

Biogen